Biotech entity

Soleno Therapeutics, Inc.

Company

pharma is the sole category represented across all 1 tracked stories. Soleno Therapeutics, Inc. is most often covered alongside Schall Law Firm, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3.6 for the same window.

Last mentioned: Mar 12, 2026

Entity pulse

Recent coverage · Soleno Therapeutics, Inc.

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Soleno Therapeutics, Inc.

pharma is the sole category represented across all 1 tracked stories. Soleno Therapeutics, Inc. is most often covered alongside Schall Law Firm, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3.6 for the same window. The 5 average consequence score is below the beat benchmark of 6 in the same window. We currently track 1 Biotech story that mention Soleno Therapeutics, Inc., all published on March 12, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Soleno Therapeutics, Inc.. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Litigation Commencement

    Schall Law Firm announces class action lawsuits against both SLNO and RARE.

  2. Soleno Executive Turnover

    Official filing confirms the departure of several directors and officers.

  3. Soleno Financial Results

    Soleno files annual results and operational updates.

  4. Ultragenyx Restructuring Disclosure

    Company files SEC report detailing costs for exit or disposal activities.

Stories mentioning Soleno Therapeutics, Inc. 1

Soleno Therapeutics, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.